ClinVar Miner

Submissions for variant NM_003001.5(SDHC):c.173T>C (p.Ile58Thr)

dbSNP: rs999134407
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001898711 SCV002173675 uncertain significance Gastrointestinal stromal tumor; Paragangliomas 3 2022-11-13 criteria provided, single submitter clinical testing ClinVar contains an entry for this variant (Variation ID: 1403117). This missense change has been observed in individual(s) with head and neck paraganglioma (PMID: 19351833). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 58 of the SDHC protein (p.Ile58Thr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect SDHC function (PMID: 23175444). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0").
Ambry Genetics RCV003303349 SCV004000442 uncertain significance Hereditary cancer-predisposing syndrome 2023-05-03 criteria provided, single submitter clinical testing The p.I58T variant (also known as c.173T>C), located in coding exon 3 of the SDHC gene, results from a T to C substitution at nucleotide position 173. The isoleucine at codon 58 is replaced by threonine, an amino acid with similar properties. In a study of 598 unrelated probands diagnosed with head and neck paraganglioma, this alteration was detected in 1 individual (Neumann HP et al. Cancer Res, 2009 Apr;69:3650-6). In a yeast-based functional study, this alteration demonstrated normal function (Panizza E et al. Hum Mol Genet, 2013 Feb;22:804-15). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.